The real breakthrough occurred when researchers paired NAD+ therapy with a powerful compound that your body cant produce on its own, called 5-Amino-1MQ
Typical injectable GHK-Cu dose ranges Standard starting dose: 1 mg per day subcutaneous Conservative / beginner dose: 0.5 mg per day Intensive / wound-healing dose: 23 mg per day Upper research range: 4 mg per day (rarely exceeded) Frequency: once daily, or split into morning + evening microdoses for steadier levels Route: subcutaneous (SC) injection - typically abdomen , thigh or flank
Injection-site reactions are among the most commonly reported side effects: patients may experience pain, stinging, or mild burning at the IM injection site
By inhibiting NNMT, 5-Amino-1MQ may spare nicotinamide for NAD+ synthesis, thereby activating SIRT1 (Sirtuin 1) pathways associated with mitochondrial biogenesis and fat oxidation
Clinical trials involving approximately 900 participants showed that AOD-9604 had no effect on IGF-1 levels and no negative effects on carbohydrate metabolism
The vitamin is injected directly into muscle (intramuscular) or under the skin (subcutaneous) and is released gradually into the bloodstream